Multidisciplinary Care Model and Contemporary Strategies for Intrathecal Drug Delivery (203)

11 am–12 pm Friday, April 27

View a recording of this live session when you purchase 2018 Annual Meeting On Demand.

Review recent notable changes in the management strategies for patients with a targeted drug delivery system. Speakers will also discuss safety, efficacy, and best practices when employing intrathecal therapy. Pharmacodynamic risks will be compared with oral analgesics, including the risk of respiratory depression, endocrinopathy, hyperalgesia, and addiction. Systemic opioid cessation will be discussed alongside an appraisal of the economics of utilizing targeted drug delivery in a contemporary pain practice. 

Comparison of Intrathecal and Oral Analgesics: Selected Adverse Effects and Efficacy

Michael S. Leong, MD

Intrathecal Drug Delivery: Is Bolus Administration Better than Continuous?

Jason E. Pope, MD

Cost-Effectiveness of Targeted Drug Delivery

Robert Bolash, MD

Learning Objectives:

  • Present the current best practice intrathecal treatments.
  • Demonstrate cost-effectiveness data about intrathecal therapy compared with conservative multidisciplinary care.
  • Select optimal patients for intrathecal therapy and adjust dosages, including tapering off intrathecal medications.